UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051959
Receipt number R000059303
Scientific Title Effects of a dairy ingredient on iron metabolism in healthy female subjects: a randomized, double-blind, placebo-controlled, parallel group, comparative superiority trial
Date of disclosure of the study information 2023/08/21
Last modified on 2024/02/20 10:21:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of a dairy ingredient on iron metabolism in healthy female subjects: a randomized, double-blind, placebo-controlled, parallel group, comparative superiority trial

Acronym

Effects of a dairy ingredient on iron metabolism in healthy female subjects

Scientific Title

Effects of a dairy ingredient on iron metabolism in healthy female subjects: a randomized, double-blind, placebo-controlled, parallel group, comparative superiority trial

Scientific Title:Acronym

Effects of a dairy ingredient on iron metabolism in healthy female subjects

Region

Japan


Condition

Condition

None (Healthy subjects)

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of a dairy ingredient on iron metabolism.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

indices of iron metabolism

Key secondary outcomes

indices of iron metabolism


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingestion of dairy ingredient for 4 weeks.

Interventions/Control_2

Ingestion of placebo for 4 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

50 years-old >

Gender

Female

Key inclusion criteria

1)Female
2)Subjects between 18 to 50 years old.
3)Serum ferritin >= 12 ng/mL

Key exclusion criteria

1)Blood hemoglobin < 12 g/dL
2)Subjects who undergoes treatment for iron deficiency or anemia
3)Menopausal
4)Subjects who plans to donate blood during the test period
5)Subjects who regularly consume foods containing a dairy ingredient to be evaluated.
6)Subjects who take medicines or functional foods during the pre-test period, which might affect their iron metabolism.
7)Subjects who cannot stop taking medicines or functional foods during the test period, which might affect their iron metabolism.
8)Subjects who have serious disease in the liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, or metabolic system etc. Or those who have serious medical history of these.
9)Subjects having a milk allergy.
10)Subjects who have medical history of drug allergy or severe food allergy
11)Subjects who are pregnant or under lactation, or who is expected to be pregnant during the study.
12)Subjects who donated 400 mL of their blood within 12 weeks before the beginning of test-food intakes, or not less than 200 mL of their blood during the pre-test period.
13)Others who have been determined as ineligible for the research subject of this study, judging from the principal researcher/doctor's opinions on the findings of their background, physical observations, medical checkup, physical/clinical examination, and so on.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Yoshida

Organization

Kyushu University of Health and Welfare

Division name

Department of Pharmacy, Faculty of Pharmaceutical Sciences

Zip code

882-8508

Address

1714-1, Yoshino, Nobeoka, Miyazaki

TEL

0982-23-5574

Email

h-yoshida@phoenix.ac.jp


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Yoshida

Organization

Kyushu University of Health and Welfare

Division name

Department of Pharmacy, Faculty of Pharmaceutical Sciences

Zip code

882-8508

Address

1714-1, Yoshino, Nobeoka, Miyazaki

TEL

0982-23-5574

Homepage URL


Email

h-yoshida@phoenix.ac.jp


Sponsor or person

Institute

Kyushu University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

Morinaga Milk Industry Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board at Kyushu University of Health and Welfare

Address

1714-1, Yoshino, Nobeoka, Miyazaki

Tel

0982-23-5574

Email

h-yoshida@phoenix.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 08 Month 11 Day

Date of IRB

2023 Year 08 Month 11 Day

Anticipated trial start date

2023 Year 08 Month 21 Day

Last follow-up date

2023 Year 12 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 08 Month 21 Day

Last modified on

2024 Year 02 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059303


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name